These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2482498)

  • 1. Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.
    Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
    Prog Clin Biol Res; 1989; 316B():281-93. PubMed ID: 2482498
    [No Abstract]   [Full Text] [Related]  

  • 2. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
    Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
    Trans Assoc Am Physicians; 1984; 97():268-74. PubMed ID: 6085528
    [No Abstract]   [Full Text] [Related]  

  • 5. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ; Charache S; Boyer SH
    Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
    [No Abstract]   [Full Text] [Related]  

  • 6. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
    Veith R; Galanello R; Papayannopoulou T; Stamatoyannopoulos G
    N Engl J Med; 1985 Dec; 313(25):1571-5. PubMed ID: 2415821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of fetal hemoglobin synthesis by cell cycle specific drugs.
    Nathan DG
    Prog Clin Biol Res; 1985; 191():475-500. PubMed ID: 2413483
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
    Galanello R; Veith R; Papayannopoulou T; Stamatoyannopoulos G
    Prog Clin Biol Res; 1985; 191():433-45. PubMed ID: 2413479
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of fetal hemoglobin production by hydroxyurea in sickle cell anemia.
    Dover GJ; Charache S
    Prog Clin Biol Res; 1989; 316B():295-306. PubMed ID: 2482499
    [No Abstract]   [Full Text] [Related]  

  • 11. Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.
    Coleman E; Inusa B
    Clin Pediatr (Phila); 2007 Jun; 46(5):386-91. PubMed ID: 17556734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
    Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

  • 14. Methotrexate stimulates fetal hemoglobin production in anemic baboons.
    Veith R; Dautenhahn AG; Roth RC
    Prog Clin Biol Res; 1989; 316B():363-70. PubMed ID: 2482503
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of sickle cell anemia with hydroxyurea and erythropoietin.
    Goldberg MA; Brugnara C; Dover GJ; Schapira L; Charache S; Bunn HF
    N Engl J Med; 1990 Aug; 323(6):366-72. PubMed ID: 1695325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H; Sutton M; Atweh GF
    Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea and sickle cell disease.
    Orringer EP; Parker JC
    Hematol Pathol; 1992; 6(4):171-8. PubMed ID: 1283391
    [No Abstract]   [Full Text] [Related]  

  • 18. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
    Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
    Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell pain & hydroxyurea.
    Day SW; Wynn LW
    Am J Nurs; 2000 Nov; 100(11):34-8; quiz 38-9. PubMed ID: 11103633
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxyurea in sickle cell disease.
    Schechter AN; Rodgers GP
    N Engl J Med; 1996 Feb; 334(5):333. PubMed ID: 8532042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.